616 results on '"Garau J"'
Search Results
2. Current management of patients hospitalized with complicated skin and soft tissue infections across Europe (2010–2011): assessment of clinical practice patterns and real-life effectiveness of antibiotics from the REACH study
3. Impact of a hand hygiene educational programme on hospital-acquired infections in medical wards
4. Guidelines for the management of adult lower respiratory tract infections - Full version
5. Guidelines for the management of adult lower respiratory tract infections - Summary
6. Cost of bacteraemia caused by methicillin-resistant vs. methicillin-susceptible Staphylococcus aureus in Spain: a retrospective cohort study
7. Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control
8. Mortalidad posthospitalaria en pacientes reingresadores por EPOC. Utilidad del índice BODE
9. Management of methicillin-resistant Staphylococcus aureus infections
10. Aetiology of community-acquired pneumonia among adults in an H1N1 pandemic year: the role of respiratory viruses
11. Factors impacting on length of stay and mortality of community-acquired pneumonia
12. Other antimicrobials of interest in the era of extended-spectrum β-lactamases: fosfomycin, nitrofurantoin and tigecycline
13. Low-dose β-lactam plus amikacin in febrile neutropenia: cefepime vs. piperacillin/tazobactam, a randomized trial
14. Bacteraemic pneumococcal pneumonia in COPD patients: better outcomes than expected
15. Risk factors for opportunistic infections in infliximab-treated patients: the importance of screening in prevention
16. Prophylaxis versus pre-emptive treatment for infective and inflammatory complications of surgical third molar removal: a randomized, double-blind, placebo-controlled, clinical trial with sustained release amoxicillin/clavulanic acid (1000/62.5 mg)
17. Role of beta-lactam agents in the treatment of community-acquired pneumonia
18. Impact of antibiotic restrictions: the ethical perspective
19. Bacteraemia Caused by Non-Glucose-Fermenting Gram-Negative Bacilli and Aeromonas Species in Patients with Haematological Malignancies and Solid Tumours
20. Current management of patients hospitalised with community-acquired pneumonia across Europe (2010- 2011): assessment of clinical practice patterns and real-life effectiveness of antibiotics (REACH study): O174
21. Health economic analysis of current clinical management of patients hospitalised with community-acquired pneumonia across Europe (2010-2011) (REACH study): use of resources and consequences of treatment failure: O175
22. The epidemiology of domestic injurious falls in a community dwelling elderly population: an outgrowing economic burden
23. The bacterial challenge: time to react: S413
24. Serious Gram-positive infections: the need for new treatment options: S301-S304
25. A preventable killer: Pneumonia
26. New insights concerning methicillin-resistant Staphylococcus aureus disease
27. Prospective, randomised, multicentre study of meropenem versus imipenem/cilastatin as empiric monotherapy in severe nosocomial infections
28. Pseudomonas aeruginosa in sputum at admission in hospitalised patients for acute COPD exacerbation: prognostic implications: O31
29. Healthcare-associated bacteraemic pneumonia: aetiology, severity of disease and outcomes: O26
30. Living with ESBLs
31. Seven-year review of bacteremia caused byStreptococcus milleri and other viridans streptococci
32. Relationship between outer membrane protein profiles and resistance to ceftazidime, imipenem, and ciprofloxacin inPseudomonas aeruginosa isolates from bacteremic patients
33. Tuberculosis in the very old: a ten-year experience: O470
34. Predictors of positive microbiology in community-acquired pneumonia subjects: results of a multivariate analysis: O412
35. Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine
36. Prospective epidemiological study of invasiveHaemophilus influenzae disease in adults
37. Beta-lactamases: Current situation and clinical importance
38. Both penicillin and amoxycillin should be tested in antimicrobial surveillance for Streptococcus pneumoniae
39. Significance of staphylococcal bacteruria in the course of S. aureus bacteraemia: P1696
40. Hospital differences in the diagnostic microbiological workup in patients admitted to hospital with community-acquired pneumonia in Spain: P1337
41. Clinical presentation of community-acquired pneumonia in adults admitted to hospital in Spain: P1338
42. Streptococcus pneumoniae spinal infection: P1185
43. Preferred first line antibiotics in adult CAP admitted to hospital in Spain: P887
44. Corticosteroids in patients with severe community-acquired pneumonia: impact on mortality: P881
45. Performance in practice: bacteriological efficacy in patients with drug‐resistant S. pneumoniae
46. Paradoxical response in infliximab-treated patients with disseminated tuberculosis
47. Risk factors for community-acquired infections due to Escherichia coli harbouring extended-spectrum-beta-lactamases
48. Epidemiology of hospitalised patients with AECB (acute exacerbation of chronic bronchitis) and Gram-negative bacilli in the sputum
49. Factors behind the resistance
50. Surveillance hot spots: the highs and lows of regional resistance. Europe North and South
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.